Stay updated with breaking news from Rxsight Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
ZUG, Switzerland, May 30, 2024 -- Shareholders approved all agenda items and proposals of the Board of DirectorsRobert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members...
The Medical Instruments industry has been witnessing a gradual transition from remote healthcare and contactless services during the pandemic to its original space of point-of-care testing, heavy as well as minimally invasive implants, elective procedures, and so on. This industry is highly fragmented, with participants engaged in research and development (R&D) in therapeutic areas.
RxSight, Inc. (NASDAQ:RXST – Get Free Report) has earned a consensus rating of “Buy” from the seven brokerages that are currently covering the firm, MarketBeat.com reports. Seven research analysts have rated the stock with a buy rating. The average twelve-month price target among analysts that have updated their coverage on the stock in the last […]
Lisanti Capital Growth LLC lessened its position in RxSight, Inc. (NASDAQ:RXST – Free Report) by 10.1% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 110,820 shares of the company’s stock after selling 12,385 shares during the quarter. Lisanti Capital Growth LLC […]
ALISO VIEJO, Calif., May 06, 2024 -- – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today...